Protocol for Outpatient Dexamethasone Suppression Test
The overnight 1-mg dexamethasone suppression test (DST) is the recommended protocol for outpatient screening of Cushing's syndrome, with dexamethasone administered at 11:00 PM and cortisol measured between 8:00-9:00 AM the following morning. 1
Standard Protocol for Overnight DST
Preparation:
- Ensure patient is not taking medications that interfere with dexamethasone metabolism (particularly CYP3A4 inducers)
- Women on estrogen-containing oral contraceptives may have false positive results 2
Test Administration:
Sample Collection:
Result Interpretation:
Special Considerations
For Obese Patients
- False positive rates of 2.3% have been reported with the 1-mg DST in obese patients 3
- Consider using a 2-mg overnight DST for obese patients, which has shown a lower false positive rate (2% vs 8% with 1-mg test) 5
Potential Pitfalls
False positives may occur due to:
- Rapid absorption/malabsorption of dexamethasone
- Medications affecting dexamethasone metabolism
- Increased corticosteroid binding globulin levels
- Pseudo-Cushing's states (psychiatric disorders, alcohol use disorder, severe obesity) 1
False negatives may occur due to:
- Medications inhibiting dexamethasone metabolism
- Cyclic Cushing's syndrome 1
Follow-up Testing
- If DST is positive (non-suppression of cortisol), confirm with additional tests:
- 24-hour urinary free cortisol (UFC)
- Late-night salivary cortisol (LNSC)
- Low-dose dexamethasone suppression test (0.5 mg every 6 hours for 2 days) 3
Alternative Protocols
- For shift workers or patients with disrupted circadian rhythm, DST is preferred over other tests 1
- For suspected adrenal tumor, DST is recommended as the initial test 1
- For suspected cyclic Cushing's syndrome, LNSC may be more appropriate 1
The overnight 1-mg DST remains a reliable and convenient screening test for Cushing's syndrome in the outpatient setting, with good sensitivity and specificity when properly administered and interpreted.